Evidence map›Paper›PMID 34277447›Full record

ArticleFrontiers in oncology2021

Christian Philipp Reinert, Christina Pfannenberg, Sergios Gatidis, Christian la Fougère, Konstantin Nikolaou, Sebastian Hoefert

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Christian Philipp ReinertDepartment of Radiology, Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany.
Christina PfannenbergDepartment of Radiology, Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany.
Sergios GatidisDepartment of Radiology, Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany.
Christian la FougèreDepartment of Radiology, Nuclear Medicine, University Hospital Tübingen, Tübingen, Germany.
Konstantin NikolaouDepartment of Radiology, Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany.
Sebastian HoefertDepartment of Oral and Maxillofacial Surgery, University Hospital of Tübingen, Tübingen, Germany.
University Children's Hospital Tübingen · DEDeutschen Konsortium für Translationale Krebsforschung · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medication-related osteonecrosis of the jaw (MRONJ) is a serious side effect in antiresorptive treatment. Treatment of MRONJ is considered primarily conservative with oral mouth rinses and antibiotics but may demand surgery, depending on the complaints and general condition of the patient, the extent of the necrosis, and the overall prognosis with respect to the underlying disease. A 77 year old female patient with invasive ductal breast cancer and bone metastases was treated with intravenous bisphosphonate (BP) zoledronic acid. During therapy, she developed MRONJ in the mandible with severe pain. Clinical examination revealed confluent exposed bone of the lower left jaw and a fistula at the right molar region. The panoramic radiograph revealed a mandibular osseous involvement with diffuse radiopaque areas between radiolucent areas. For preoperative planning,

Indexed as

18F-fluorideantiresorptive therapybisphosphonateshybrid imagingmedication-related osteonecrosis of the jawPET/CT

Identifiers

PMID34277447
PMCPMC8281890
OpenAlexW3183822794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.